Non conventional mutations associated with myeloproliferative disorders are absent in splanchnic venous thrombosis cases

Liver International

Volumn 32, Issue 10, 2012, Pages 1596-1597

  Jadli, Anshul ^a   Kulkarni, Bipin ^a   Ghosh, Kanjaksha ^a   Shetty, Shrimati ^a  

^a NATIONAL INSTITUTE OF IMMUNOHAEMATOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2; PHENYLALANINE; VALINE;

AMINO ACID SUBSTITUTION; BUDD CHIARI SYNDROME; HUMAN; INDIA; LETTER; MYELOPROLIFERATIVE DISORDER; PORTAL VEIN THROMBOSIS; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; SPLANCHNIC BLOOD FLOW;

ADOLESCENT; ADULT; BUDD-CHIARI SYNDROME; CHILD; FEMALE; HUMANS; INDIA; JANUS KINASE 2; MALE; MUTATION, MISSENSE; MYELOPROLIFERATIVE DISORDERS; PORTAL VEIN;

EID: 84867102042     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2012.02851.x     Document Type: Letter

References (8)

1. Kiladjian JJ, Cervantes F, Leebeek FW, et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood 2008; 111: 4922-9.
2. Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India. Hepatology 2001; 34: 666-70.
3. Shetty S, Kulkarni B, Pai N, et al. JAK2 mutations across a spectrum of venous thrombosis cases. Am J Clin Pathol 2010; 134: 82-5.
4. Schafer AI. Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia. Blood 2006; 107: 4214-22.
5. Reilly JT. Idiopathic myelofibrosis: pathogenesis to treatment. Hematol Oncol 2006; 24: 56-63.
6. Regina S, Herault O, D'Alteroche L, Binet C, Gruel Y. JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis. J Thromb Haemost 2007; 5: 859-61.
7. Tefferi A. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 2010; 24: 1128-38.
8. Bergamaschi GM, Primignani M, Barosi G, et al. MPL and JAK2 exon 12 mutations in patients with the Budd-Chiari syndrome or extrahepatic portal vein obstruction. Blood 2008; 111: 4418.